- Staat
- CA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 29.09.2021
- Impfdatum
- 29.09.2021
- Beginn
- 29.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Syncope
Tremor
Symptomtext
DIZZINESS, SHAKING, FAINT AT 12:05PM FOR 10 SECONDS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- UNKOWN
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.10.2022
- Impfdatum
- 01.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blindness
Condition aggravated
Laboratory test
Scan abnormal
Symptomtext
Loss of vision/95% of vision gone; Condition aggravated; This case was reported by a consumer and described the occurrence of loss of vision in a patient who received Herpes zoster (Shingles vaccine) (batch number P7N2H, expiry date 30th January 2023) for prophylaxis. Concurrent medical conditions included swelling of retina (vision issues with a swollen retina in the right eye in July 2022), poor vision (limited vision in left eye due to explosion) and abnormal vision. On 1st August 2022, the patient received Shingles vaccine. On 2nd August 2022, 1 days after receiving Shingles vaccine, the patient experienced loss of vision (serious criteria GSK medically significant) and condition aggravated. On an unknown date, the outcome of the loss of vision and condition aggravated were not recovered/not resolved. It was unknown if the reporter considered the loss of vision and condition aggravated to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 06-OCT-2022 Reporter's Comment: The case was self reported by the patient. The patient received a dose of Shingles vaccine and had vision issues with a swollen retina in the right eye. The patient received shingles vaccine and woke up the next morning with 95 percent of vision gone and vision had not returned to date. Retina Specialist was shocked when he did a retinal scan the end of August. It clearly shown the vision gone from clear with some dots in July to 95 percent dark on the next retinal scan the end of August 2022. The patient reported that he/she who had very limited vision in left eye due to explosion and now no vision in right eye.The reporter would appreciate a response as soon as possible.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- Test Date: 202207; Test Name: Laboratory test; Result Unstructured Data: (Test Result:see text,Unit:unknown,Normal Low:,Normal High:) It clearly shown the vision gone from clear with some dots in July to 95 percent dark on the next retinal scan the end of August; Test Date: 202208; Test Name: Laboratory test; Result Unstructured Data: (Test Result:see text,Unit:unknown,Normal Low:,Normal High:) It clearly shown the vision gone from clear with some dots in July to 95 percent dark on the next retinal scan the end of August
- Aktuelle Erkrankungen
- Abnormal vision; Poor vision (limited vision in left eye due to explosion); Swelling of retina (vision issues with a swollen retina in the right eye in July 2022)
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 13.04.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Condition aggravated
Injected limb mobility decreased
Injection site pain
Motor dysfunction
Muscular weakness
Tremor
Symptomtext
Site: Pain at Injection Site-Severe, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: Patient states cannot lift her right arm and it shakes when she lifts her arm. There is constant pain at the injection site that is tender to touch and the pain is getting worse. She has a hard time gripping with her hand when she lifts her arm. Her arm feels weak.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 11.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 10.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Heart rate increased
Heart rate irregular
Oxygen saturation decreased
Symptomtext
elevated and irregular heart beat, difficulty breathing, low co2 count
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- shingrix 10/13/2021
- Staat
- GA
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 22.01.2022
- Impfdatum
- 12.10.2021
- Beginn
- 13.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injected limb mobility decreased
Injection site reaction
Pain in extremity
X-ray normal
Symptomtext
patient called pharmacy and reported a severe site reaction, she can not move her arm and the arm is very soar. patient went to doctor and did x-ray but not damage was showing in the x-ray. patient said that she had tried topical cream to relieve the pain but no success.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- do not know
- Andere Medikamente
- not listed
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 11.11.2021
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Discomfort
Immediate post-injection reaction
Impaired work ability
Magnetic resonance imaging
Mobility decreased
Pain
X-ray
Symptomtext
I had pain and pressure immediately after injection, within two hours it was 10/10 pain. I went to the ER. I was given 300mg of Gabapentin with no relief. I was unable to work fo the next 5 days, and continued to have 8/10 pain at rest and loss of range of motion. Now 16 days post injection I continue to have resting pain and limited range of motion. My primary doctor scheduled me for a MRI.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- x-ray 10/26/2021 MRI 11/16/2021
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Vitamin D3
- Allergien
- Bees
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 08.10.2021
- Impfdatum
- 06.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Hypoaesthesia
Hypoaesthesia oral
Paraesthesia
Symptomtext
Patient received 2 vaccinations (Shingrix and Flublok) on October 6, 2021. She reported prominent numbness/tingling in her fingertips on both hands, mild numbness in her lips and cheeks, and numbness/weakness in her knees on October 8, 2021. She was counseled to watch the symptoms and report them to her prescriber if they did not improved or resolve in a few days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Flublok Methocarbamol Metoprolol ER KCl HCTZ Atorvastatin Sertraline Omeprazole
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 07.10.2021
- Impfdatum
- 04.10.2021
- Beginn
- 06.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injected limb mobility decreased
Injection site rash
Injection site swelling
Injection site warmth
Pain
Pain in extremity
Symptomtext
Patient received 3 vaccines on 10/4/21. Received Shingrix in right arm and both Pneumovax 23 and Flublok in left arm. (PPSV23 lower and to right, Flublock upper and to left from ppsv23 separated by at least 1 inch.) Patient called today 10/7/21 stating the following reaction in left arm. Patient had pain in arm which has been improving. Very sore where patient really unable to use at beginning. She says pain has been an ache but now more of a throb. She checked arm yesterday and noticed a rash. Says rash is spreading, larger area today. covers top half circumference of her arm, (180 degree circumference.) Width is about 3 inches (top to bottom). She says the area is warm to the touch. No itching. When I asked her if the area was swollen she said she thinks so. She has been taking tylenol and ibuprofen which she says has not been helping much, She has been icing the area and says she was putting hydrocortisone cream on the area. Patient states no fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 04.10.2021
- Impfdatum
- 23.09.2021
- Beginn
- 24.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal rigidity
Fatigue
Headache
Herpes zoster
Mobility decreased
Blister
Pain
Muscle spasms
Rash erythematous
Rash
Rash papular
Symptomtext
Shingles; Fluid filled blisters; red raised rash; Fatigue; Headache; Shooting pain in body; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 23rd September 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 24th September 2021, 1 days after receiving Shingrix, the patient experienced fatigue, headache and shooting pain. On 26th September 2021, the patient experienced red rash. On 27th September 2021, the patient experienced shingles and blister. The patient was treated with valaciclovir (Valacyclovir). On an unknown date, the outcome of the fatigue, headache, shooting pain, red rash, shingles and blister were not recovered/not resolved. It was unknown if the reporter considered the fatigue, headache, shooting pain, red rash, shingles and blister to be related to Shingrix. Additional details were provided as follows: This case was reported by the patient herself. The age at vaccination was not reported. The patient received the dose of Shingrix and the next day on the 24th September 2012, she began to experience fatigue, headache and shooting pain in her body. By 26 September 2021, she had developed a red raised rash and by 27th September 2021 was diagnosed with shingles and had fluid filled blisters. None of these symptoms have resolved. She reported that she was currently being treated with valacyclovir. She also stated that she had reported this online in the VAERS system. The reporter consented to follow up. The reporter had requested to contact from safety department concerning her case by phone call or personalized follow up letter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Test Name: Laboratory test; Result Unstructured Data: (Test Result:was diagnosed with shingles,Unit:unknown,Normal Low:,Normal High:)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 04.10.2021
- Impfdatum
- 23.09.2021
- Beginn
- 24.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal rigidity
Fatigue
Headache
Herpes zoster
Mobility decreased
Blister
Pain
Muscle spasms
Rash erythematous
Rash
Rash papular
Symptomtext
Shingles; Fluid filled blisters; red raised rash; Fatigue; Headache; Shooting pain in body; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 23rd September 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 24th September 2021, 1 days after receiving Shingrix, the patient experienced fatigue, headache and shooting pain. On 26th September 2021, the patient experienced red rash. On 27th September 2021, the patient experienced shingles and blister. The patient was treated with valaciclovir (Valacyclovir). On an unknown date, the outcome of the fatigue, headache, shooting pain, red rash, shingles and blister were not recovered/not resolved. It was unknown if the reporter considered the fatigue, headache, shooting pain, red rash, shingles and blister to be related to Shingrix. Additional details were provided as follows: This case was reported by the patient herself. The age at vaccination was not reported. The patient received the dose of Shingrix and the next day on the 24th September 2012, she began to experience fatigue, headache and shooting pain in her body. By 26 September 2021, she had developed a red raised rash and by 27th September 2021 was diagnosed with shingles and had fluid filled blisters. None of these symptoms have resolved. She reported that she was currently being treated with valacyclovir. She also stated that she had reported this online in the VAERS system. The reporter consented to follow up. The reporter had requested to contact from safety department concerning her case by phone call or personalized follow up letter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Test Name: Laboratory test; Result Unstructured Data: (Test Result:was diagnosed with shingles,Unit:unknown,Normal Low:,Normal High:)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 02.05.2022
- Impfdatum
- 05.10.2021
- Beginn
- 02.05.2022
- Tage bis Beginn
- 209,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Herpes zoster
Pain in extremity
Symptomtext
Pt states her arm is red and sore and she has had several instances of shingles on her body since she received her vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 06.02.2022
- Impfdatum
- 24.11.2021
- Beginn
- 28.11.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Adverse event
Aphasia
Fatigue
Feeling abnormal
Memory impairment
Symptomtext
The flu Vaccine was given on 11/24/2021 and then 2 days later both the Moderna and Shingrix vaccines were given on 11/26/2021. Following the Moderna and Shingrix vaccinations the pt reports becoming very tired and "walloped" on or about 11/28/2021. Pt reports that it became and to some extent still is "difficult in having an intelligent conversation with others (and wife)". He has had difficulties in memory and in tasks out in public such as running a debit card as he forgets the pin. Pt reports that he has never had such memory problems prior to the vaccinations and was always the one "to remember things and be the sharp one in the room". The Patient was able to recall jobs and history while on the phone but still states he feels fuzzy or clouded at times. Pt states he did not report this adverse event and I discovered this during the follow-up call for the second shingrix vaccine the Pt is due.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- NONE - As a note the Pt has no PCP at this time and I recommended the Pt establish care with a New PCP as his old primary care MD retired and I asked him to report this reaction and get medical advice on this reaction, and his continued symptoms. The Pt sounded coherent and of sound mind on the call 02/06/2022, and said he will work on establishing a new PCP and reporting this to them.
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None known
- Andere Medikamente
- None on file
- Allergien
- None reported
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 22.10.2021
- Impfdatum
- 20.09.2021
- Beginn
- 25.09.2021
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Burning sensation
Erythema
Rash
Symptomtext
5 days after vaccine, husband noticed non-painful large bright pink/red area with bumps right popliteal area and small red area with bumps on rt. achilles tendon. (redness could have occurred earlier but not noticed) Next day red with bumps area upper, inner posterior right thigh, then couple of days later a red area with bumps lower buttocks. All rash areas in line up leg. 5 days after rash appeared the redness decreased and there was burning especially popliteal area that would be for a day or two then return every couple of days. There still is mild burning off and on. I have thalamic pain syndrome with burning in various areas so didn't realize this burning was at the rash area. No treatment as pain not severe and way past the 48 hours for medication when realized and I was on a trip across the country.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Non-ischemic cardiomyopathy; Thalamic hemorrhage with resultant hemiparesis right side; aphasia and thalamic pain syndrome; Mild dyslipidemia
- Andere Medikamente
- losartan, metoprolol er, baclofen, nortriptyline, alprazolam, magnesium, glucosamine/chondroitin/msm, fish oil, biotin, vit. D.
- Allergien
- Amoxicillin, cephalexin, septra: all rashes. Amiodaron: psychiatric and G.I. pain with decreased appetite.
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 21.10.2021
- Impfdatum
- 16.10.2021
- Beginn
- 20.10.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site inflammation
Injection site reaction
Injection site warmth
Rash
Rash erythematous
Rash pruritic
Symptomtext
inflamed bumpy red patch approximately 2-1/2? x 2-1/2? just below injection site. Red patch is warm to the touch and itchy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site inflammation
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Narcolepsy
- Andere Medikamente
- Methylphenidate, ibuprofen, cranberry, turmeric, bioastin, vitamin c, biotin, mircette
- Allergien
- Sulfa, penicillin, latex, adhesive
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 13.10.2021
- Beginn
- 14.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site erythema
Injection site inflammation
Injection site warmth
Symptomtext
Big round red inflammed arear on left arm that is warm to the touch on the left arm that she got the shingrix and adacel in
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 19.10.2021
- Impfdatum
- 06.10.2021
- Beginn
- 07.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Rash erythematous
Rash papular
Rash pruritic
Symptomtext
Patient reports red, bumpy, itchy rash that appeared on her abdomen from her breast to her belly button on 10/7/21. Patient reported negative for new soaps, detergents or medications. She also stated that she had a similar reaction with her Clindamycin allergic reaction. Rash resolved in 2-3 days after patient took benadryl. Patient has never had a reaction to a Flu shot in the past and does not think that the reaction is from the Flu shot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- none reported
- Andere Medikamente
- none reported
- Allergien
- clindamycin, azithromycin
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 14.10.2021
- Impfdatum
- 20.09.2021
- Beginn
- 21.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Cellulitis
Erythema
Pruritus
Swelling
Symptomtext
After Shingrix vaccine on 9/20/21 site began swelling and itching and turning red 9/21. Continued to worsen and she went to urgent care 9/24 where diagnosed with cellulitis. redness too deltoid area to below elbow. treated with Keflex 500mg 4 x daily. followed up with Dr. 10/8 and still a few spots and small amount of redness. PCP unsure cellulitis vs normal strong Shingrix reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hx colon cancer; Hashimoto's hypothyroid; asthma; osteoarthritis/porosis
- Andere Medikamente
- 5-hydroxytryptophan 100 mg; advair inhaler; Bromelains 1000 mg; Vitamin D3 10,000 IU; chromium 500 mcg; cromolyn nasal spray; Vitamin B12 5,000 mcg; Pepcid 40 mg; epi pen prn; Flovent inhaler; synthroid 112 mcg; Cytomel 2.5 mcg; lisinopril
- Allergien
- Lactose; prilosec; coedeine; provera; singulair; potassium; shrimp
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 07.10.2021
- Impfdatum
- 07.10.2021
- Beginn
- 07.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Rash
Urticaria
Symptomtext
patient returned to pharmacy in about an hour to an hour and a half with rash/hives she stated she called her Provider and they instructed her to take a benadryl and the patient has an appointment in the morining patient returned about 30 to 45 minutes later and we agreed she should go to a minor emergency center for the rash
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- pending
- Aktuelle Erkrankungen
- seasonal allergies
- Vorgeschichte
- none listed
- Andere Medikamente
- not available
- Allergien
- none listed
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 07.10.2021
- Impfdatum
- 20.09.2021
- Beginn
- 27.09.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes simplex
Rash
Vaccine positive rechallenge
Symptomtext
breakout Herpes Simplex rash; rash; This case was reported by a consumer via call center representative and described the occurrence of herpes simplex in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number P7N2H, expiry date 30th January 2023) for prophylaxis. The patient's past medical history included herpes simplex. Previously administered products included Shingrix with an associated reaction of herpes simplex (1st dose received on 16th July 2021, refer case US2021205534). On 20th September 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 27th September 2021, 7 days after receiving Shingrix, the patient experienced herpes simplex and rash. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the herpes simplex and rash were unknown. It was unknown if the reporter considered the herpes simplex and rash to be related to Shingrix. Additional information was provided as follows: The reporter was the patient. She received her 2nd shingrix dose and 7 days later developed a rash that she describes as breakout Herpes Simplex rash on her her right side. No additional information was provided. The reporter consented to follow up.; Sender's Comments: US-GLAXOSMITHKLINE-US2021205534:same patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Herpes simplex
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 27.09.2021
- Impfdatum
- 20.09.2021
- Beginn
- 01.09.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain in extremity
Symptomtext
Redness; Sore arm; This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a 85-year-old female patient who received Herpes zoster (Shingrix) (batch number P7N2H, expiry date 30th January 2023) for prophylaxis. On 20th September 2021, the patient received the 1st dose of Shingrix. In September 2021, less than a week after receiving Shingrix, the patient experienced erythema and pain in arm. On an unknown date, the outcome of the erythema was recovering/resolving and the outcome of the pain in arm was unknown. It was unknown if the reporter considered the erythema and pain in arm to be related to Shingrix. Additional details were provided as follows: The pharmacist reported that the patient experienced redness and a sore arm after dose one of Shingrix. The patient came to the pharmacy and showed the redness and it had already begun to fade and the current status was unknown. Health care professional noted that she had a picture she could send if safety required it and asked to request during follow-up if photo was required. The reporter did not provide address details. The reporter consented to follow up. No additional information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 24.09.2021
- Impfdatum
- 23.09.2021
- Beginn
- 24.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Influenza virus test
Nausea
Pyrexia
Streptococcus test
Symptomtext
Fever 104.9, chills, and nausea.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Rapid strep and rapid influenza
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma as a child, Psoriasis
- Andere Medikamente
- Alternating Acetaminophen and Ibuprofen.
- Allergien
- Codeine and Aminophylline
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 18.09.2021
- Beginn
- 18.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Feeling hot
Injection site swelling
Symptomtext
swelling at or just below injection site, redness, felt hot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 20.09.2021
- Beginn
- 21.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blister
Burning sensation
Herpes zoster
Rash
Symptomtext
24 hours after patient received Shingrix vaccine she began to notice a shingles like rash on her left chest that radiated down her left arm. She began experiencing a burning, painful rash in the same area as her blisters. She presented to the clinic 9/22/21 for evaluation of her rash and was diagnosed with shingles. Valacyclovir 1 gm every 8 hours for 7 days prescribed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No acute illnesses at time of vaccination or up to one month prior.
- Vorgeschichte
- Essential hypertension; Mixed hyperlipidemia; Type 2 diabetes mellitus with hyperglycemia without long-term use of insulin; Mild intermittent asthma without complication; Stress incontinence; Arthritis; Metabolic syndrome; Obesity
- Andere Medikamente
- Aspirin; Flonase; Glipizide; Metformin; Metoprolol XL; Montelukast; Oxybutynin; Potassium; Chloride; Triamterene-hydrochlorothiazide; Victoza
- Allergien
- Bactrim; Sulfa antibiotics
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 21.09.2021
- Impfdatum
- 14.09.2021
- Beginn
- 14.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Feeling hot
Pain
Rash
Symptomtext
Patient reports a rash hot and painful size of a small tangerine, asked her to take a photo and follow up with md if getting worst. ice and benedryl if needed. Patient got prescription for bactrim ds for 7 days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 21.09.2021
- Impfdatum
- 21.09.2021
- Beginn
- 21.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Feeling hot
Hyperhidrosis
Pallor
Skin discolouration
Symptomtext
Patient received shingrix vaccine in her left arm first, she said her arm was already starting to feel sore as I was prepping for the flu shot to be injected into her right arm. Soon after getting the fluzone HD, patient tells me that she's dizzy and would like to stay seated. I noticed she was turning pale, so I gave her an extra chair to elevate her legs. I had my technician call 911 in the meantime. Patient was feeling hot and started to sweat, I gave her some water when she told me she "was coming back." she started to feel better but I noticed her fingers in the right hand were turning reddish-blue. That's when EMS came and took her blood pressure, her BP was 80/46 so they took her to the hospital immediately. Patient hadn't had anything to eat ever since she woke up in the morning
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- prevnar vaccine
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 18.09.2021
- Impfdatum
- 17.09.2021
- Beginn
- 17.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
LARGE SWELLING AND REDNESS AROUND INJECTION SITE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- CHOLESTEROL
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 04.03.2023
- Impfdatum
- 26.11.2021
- Beginn
- 27.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anxiety
Blister
Herpes zoster
Post herpetic neuralgia
Quality of life decreased
Symptomtext
constant nerve pain now, destructive to my life/ nerve pain PHN; anxiety; This ongoing issue has been very destructive to my life; Large blisters; constant shingle outbreaks, breaking point for overall health/6+ times is now a breaking point for me/ outbreak on left butt check; This case was reported by a consumer and described the occurrence of shingles in a 58-year-old female patient who received Herpes zoster (Shingrix) (batch number p7n2h, expiry date unknown) for prophylaxis. Concurrent medical conditions included blood cholesterol increased, hypothyroidism and osteoarthritis. Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX), rosuvastatin, levothyroxine (Levothyroxin) and meloxicam. On 26th November 2021, the patient received the 2nd dose of Shingrix. On 27th November 2021, 1 days after receiving Shingrix, the patient experienced shingles. On 7th December 2022, the patient experienced blister. On an unknown date, the patient experienced post herpetic neuralgia, anxiety and quality of life decreased. The patient was treated with clonazepam, valaciclovir (Valacyclovir) and gabapentin. On an unknown date, the outcome of the shingles and post herpetic neuralgia were not recovered/not resolved and the outcome of the anxiety, quality of life decreased and blister were unknown. It was unknown if the reporter considered the shingles, post herpetic neuralgia, anxiety, quality of life decreased and blister to be related to Shingrix. Additional Information: GSK Receipt Date: 04-FEB-2023 Reporter's comments: The patient self-reported this case. The patient never had any issues until she got Shingrix shots. If she would had knew that, she was going to have the shingles just about every month then she would had not gotten the shots for preventing shingles, following the physician orders. This ongoing issue had been very destructive to her life with the constant nerve pain now, along with never knowing when it would arise again. Six plus times was now a breaking point for her with the anxiety and overall health (constant shingle outbreaks). The symptoms were treated. The reporter gave permission to contact. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. Adverse event (AE) outcome captured conservatively and clarification was raised to confirm the same. Follow-up information received on 22-FEB-2023 Reporter's comment: On 27th November 2021, patient had the outbreak of infection on left butt cheek which was seen and confirmed by doctor on 30th November 2021 to be shingles. On 20th February 2022, the patient saw other doctor for the same outbreak. On 23rd March 2022, the doctor already gave her refills for any outbreaks due to covid. On 8th May 2022, the doctor did not want to see her due to covid, so just called in to provided with prescription. On 9th May 2022, she had the prescription so she started it. On 10th May 2022, she called doctor but couldn't get herself in, thus started prescription immediately. On 11th May 2022, she called doctor but couldn't get herself in until 11th July 2022, but as she had already started prescription, she could not get a swab. On 12th July 2022, she just started to take prescription as the outbreak hit fast and hard with blisters within hours. On 27th December 2022, she contacted the doctor but no vacation was given, so she started to take the medication. On 3rd February 2023, she started medication immediately. When she got the shingles, she needed to get on medication as soon as possible or goes right into small blisters within 12 hours of that they were large blisters. Doctors already had made sure she had refills of the valacyclovir 1 gram tablet 3 times for 7 days. She then had to even take gabapentin 400 mg capsule 3 times daily for the nerve pain (post herpetic neuralgia). Reporters were added. Shingrix second dose was added as suspect product. Event blister was added Treatment Gabapentin drug was added. Summary of changes: General tab, Product tab, Event tab and narrative updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anxiety
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Blood cholesterol increased; Hypothyroidism; Osteoarthritis
- Vorgeschichte
- -
- Andere Medikamente
- ROSUVASTATIN; LEVOTHYROXIN; MELOXICAM
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 16.03.2022
- Impfdatum
- 15.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Patient received the 2nd dose five weeks after the 1st dose, instead of waiting the 2 to 6 month period.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- diabetes, cholesterol, high blood pressure, chronic pain
- Andere Medikamente
- Trulicity 1.5mg, vitamin d 2000, tizanidine 4mg, gabapentin 100mg, lisinopril 10mg, simvastatin 20mg, metformin 1000mg
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.12.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Medication error
Product preparation issue
Symptomtext
This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number P7N2H, expiry date 30th January 2023) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication, inappropriate dose of vaccine administered and circumstance or information capable of leading to medication error. On an unknown date, the outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and circumstance or information capable of leading to medication error were unknown. Additional details were provided as follows: The age at vaccination was not reported. The patient received only adjuvant portion of Shingrix vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter stated that, the box of 10 doses had one vial of powder remaining, so it was possible that the patient only received vial of liquid only, which led to circumstance or information capable of leading to medication error. The reporter did not determine which patient might have been impacted at this point so did not have any patient details to share yet. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 16.11.2021
- Impfdatum
- 11.11.2021
- Beginn
- 16.11.2021
- Tage bis Beginn
- 5,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
The patient was given a 3rd shot when only 2 shots are required in the series. Patient said he had not experienced any negative effects after 5 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 12.11.2021
- Impfdatum
- 17.09.2021
- Beginn
- 17.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
1st dose 07Sep2021, additional dose on 17Sep2021; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number P7N2H, expiry date 20th January 2023) for prophylaxis. Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX). On 17th September 2021, the patient received the 2nd dose of Shingrix. On 17th September 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional information was provided as follows: On 7th September 2021, the patient received 1st dose of Shingrix. The patient was administered with the first dose of Shingrix vaccine but the dose was not documented in system and an additional dose was administered at an interval shorter than the recommended, which led to shortening of vaccination schedule. The reporter stated that the patient was doing fine and had not had any issues. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 10.11.2021
- Impfdatum
- 10.11.2021
- Beginn
- 10.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient reported to pharmacy and told us that her physician told her to come get a SHINGRIX vaccine from our pharmacy. When logging into the system, it was discovered that the patient had already received 2 doses of SHINGRIX in 2018. Patient was informed and documentation was sent to prescriber.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- SHINGRIX
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product preparation issue
Symptomtext
had difficulty mixing; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number P7N2H, expiry date 30th January 2023) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication. On an unknown date, the outcome of the inappropriate preparation of medication was unknown. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, her partner pharmacist had difficulty mixing a Shingrix vaccine, which led to inappropriate preparation of medication. The reporter stated they no longer had the adjuvant vial due to this difficulty. The reporter was not sure of the details of what occurred. The reporter was unable to provide answers to questions to rule in or rule out PQC (product quality complaint). The reporter requested replacement product, but unable to provide until PQC ruled in. The reporter stated, the pharmacist directly involved with incident would call back. The patient details and PQC question answers unavailable as the reporter was not the pharmacist directly involved with incident. The reporter did not consent to follow-up. No additional details provided by the caller.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 19.10.2021
- Impfdatum
- 19.10.2021
- Beginn
- 19.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect route of product administration
Symptomtext
Shot was given subcutaneous instead of IM.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 06.10.2021
- Impfdatum
- 06.10.2021
- Beginn
- 06.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Pt was given first dose in series at our pharmacy. He came in for the follow up booster and received it. Pts wife called stating he had received the 2nd shot of the series a couple of weeks ago at a different facility
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None needed
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- S/P STROKE A FEW YEARS AGO
- Andere Medikamente
- VARIOUS. NONE RELATED TO THIS REPORT
- Allergien
- NONE LISTED
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 02.10.2021
- Impfdatum
- 02.10.2021
- Beginn
- 02.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Product administration error
Symptomtext
administration error. patient got 2 doses of shingrix at same time, one in each arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 02.10.2021
- Impfdatum
- 02.10.2021
- Beginn
- 02.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Product administration error
Symptomtext
administration error. patient got 2 doses of shingrix at same time, one in each arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 30.09.2021
- Impfdatum
- 01.09.2021
- Beginn
- 23.09.2021
- Tage bis Beginn
- 22,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Wrong product administered
Symptomtext
Incorrect vaccine given. Gave childrens dose of flu vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- chronic pancreatitis, essential hypertension, hyperlipidemia, type 2 diabetes
- Andere Medikamente
- Aspirin, cyclobenzaprine, ibuprofen, lantus, losartan, metforming, novolog, multivitamin, pravastatin, zenpep
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 29.09.2021
- Impfdatum
- 23.09.2021
- Beginn
- 23.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
3rd dose was administered; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 80-year-old male patient who received Herpes zoster (Shingrix) (batch number P7N2H, expiry date 30th January 2023) for prophylaxis. Previously administered products included Shingrix (received 1st dose in October 2019) and Shingrix (received 2nd dose in April 2020). On 23rd September 2021, the patient received the 3rd dose of Shingrix. On 23rd September 2021, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. Additional details were provided as follows: The reporter stated that, 3rd dose of Shingrix vaccine was administered to patient, which led to extra dose administered. No additional details provided by caller. The reporter did not consent to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 25.09.2021
- Impfdatum
- 25.09.2021
- Beginn
- 25.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
PATIENT CAME IN ASKING FOR SHINGRIX VACCINE. VACCINE WAS ADMINISTERED TO PATIENT, THEN PATIENT ASKED FOR DOCUMENTATION. I LOOKED UP HIS VACCINE REGISTRY TO PRINT, THEN REALIZED PATIENT FINISHED THE SERIES 3 YEARS AGO IN 2018. I ADVISED PATIENT THAT HE FINISHED THE SERIES AND THIS NOW SERVES AS A THIRD DOSE. WHEN ASKED WHY PATIENT CAME IN FOR VACCINE, PATIENT STATED THAT HE BELEIVED HE WAS SUPPOSED TO GET IT EVERY SINGLE YEAR. I ADVISED PATIENT HE IS NOW GOOD FOR LIFE, AND DOES NOT NEED TO GET THE SHINGRIX VACCINE AGAIN.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -